Impaired immune and acute-phase responses in interleukin-6-deficient mice

Manfred Köpf, Heinz Baumann, Giulia Freer, +6

Nature

InflammationCytokineAutoimmune DiseaseImmunologyAutoimmunity +4

The Role of Antibody Concentration and Avidity in Antiviral Protection

M F Bachmann, Ulrich Kalinke, Alana Althage, +6

Science

VaccinationVitro Neutralization CapacitiesAntibody ConcentrationMucosal VaccinationNeutralizing Antibodies +11

Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.

Giulia Freer, Mauro Pistello

PubMed

Veterinary VaccineImmunologyVaricella-zoster Virus InfectionEmerging Infectious DiseaseInfection Control +16

Induction of protective cytotoxic T cells with viral proteins

Martin F. Bachmann, Thomas M. Kündig, Giulia Freer, +5

European Journal of Immunology

Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen

Giulia Freer, Christoph Burkhart, I. Frank Ciernik, +3

Journal of Virology

Viral PathogenesisImmunologyImmunodominanceAntigen ProcessingViral Structural Protein +15

TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology

Mauro Pistello, Antonietta Morrica, Fabrizio Maggi, +8

Journal of Medical Virology

Ttv LoadsViral DiagnosticsTt VirusPathologyHepatic Disorders +18

Expression of Human CD81 in Transgenic Mice Does Not Confer Susceptibility to Hepatitis C Virus Infection

Francesca Masciopinto, Giulia Freer, Vito L. Burgio, +6

Virology

Autoimmune DiseaseConfer SusceptibilityViral HepatitisHuman RetrovirusImmunology +5

Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection

Kevin J. Maloy, Christoph Burkhart, Giulia Freer, +8

The Journal of Immunology

Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus

Christoph Burkhart, Giulia Freer, R.T. Castro, +4

Journal of Virology

Viral PathogenesisImmunologyImmunodominancePathologyImmunologic Mechanism +18

A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections

Flavia Chiuppesi, Laura Vannucci, Anna De Luca, +8

Journal of Virology

Veterinary VaccineImmunologyGenital HerpesPathologyImmunotherapy +14